MiR-92b targets p57kip2 to modulate the resistance of hepatocellular carcinoma (HCC) to ionizing radiation (IR) -based radiotherapy

MiR-92b targets p57kip2 to modulate the resistance of hepatocellular carcinoma (HCC) to ionizing radiation (IR) -based radiotherapy

Hepatocellular carcinoma (HCC) is one of the most common digestive system malignant tumors. Due to the resistance to radiotherapy, the prognosis in patients with HCC is poor. Based on previous studies and online tools prediction, we hypothesized that miR-92b, which was reported to promote HCC cell p...

Full description

Bibliographic Details
Main Authors: Jianyang Wang, Hong Zhao, Jing Yu, Xin Xu, Wenyang Liu, Hao Jing, Ning Li, Yuan Tang, Yexiong Li, Jianqiang Cai, Jing Jin
Format: Article
Language:English
Published: Elsevier 2019-02-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Hepatocellular carcinoma (HCC)
miR-92b
p57kip2
Radioresistance
Ionizing radiation
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332218335261

Internet

http://www.sciencedirect.com/science/article/pii/S0753332218335261

Similar Items